Physician profile
Roy Schottenfeld
NPI 1194724930
$359.11
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $14.71 · 2021: $62.48 · 2022: $129 · 2023: $19.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $94.53 | 2019 | |
| Acclarent, INC | $59.55 | 2021-2022 | |
| Alk-Abello, INC | $53.93 | 2019-2022 | |
| Optinose US, INC. | $43.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $35.71 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $22.46 | 2019 | |
| Medtronic, INC. | $17.43 | 2022 | |
| Glaxosmithkline, LLC. | $16.89 | 2022 | |
| Aerin Medical INC. | $14.71 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Schottenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.